Ob/Gyn Updated
Your Web destination for the latest in Evidence based Obstetrics, Gynecology and Women’s health.
Showing posts with label
BRCA1 mutation carrier
.
Show all posts
Showing posts with label
BRCA1 mutation carrier
.
Show all posts
Wednesday, March 29, 2017
FDA Approves PARP inhibitor Zejula for treatment of recurrent ovarian cancer.
›
courtesy: www.multivu.com The U.S.Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment of epit...
Wednesday, June 22, 2016
Osteoporosis drug can prevent the development of breast cancer in women who are BRCA1 mutation carriers.
›
Individuals who carry a mutation in breast cancer susceptibility gene(BRCA1) are highly prone to develop breast cancer. As compared to g...
›
Home
View web version
